abbvie.comAbbVie | Pharmaceutical Research & Development

AbbVie | Pharmaceutical Research & Development Africa Algeria South Africa and Sub-Saharan Africa Tunisia Asia Pacific Australia China Hong Kong Japan Korea Malaysia New Zealand Singapore Taiwan Europe Austria Belgium FR | NL Bosnia & Herzegovina Bulgaria Croatia Czech Republic Denmark Finland France Germany Greece Hungary Ireland Italy Netherlands Norway Poland Portugal Romania Russia Serbia Slovakia Slovenia Spain Sweden Switzerland DE | FR Turkey Ukraine United Kingdom Latin America / Caribbean Mexico Puerto Rico Middle East Israel Lebanon Saudi Arabia UAE North America Canada EN | FR United States South America Argentina Brazil Colombia Uruguay Global • EN Investors News Center Patients Menu Our Company Explore Our Company About AbbVie Strategy At A Glance Leadership Ethics & Compliance Explore Ethics & Compliance Ethics & Compliance Program AbbVie Code of Business Conduct Physician & Other Payments Policies & Disclosures Explore Policies & Disclosures Protecting Data Positions & Views All Stories Our Science Explore Our Science Therapeutic Focus Areas Explore Therapeutic Focus Areas Immunology Oncology Neuroscience Virology General Medicine Technologies & Platforms Pipeline Clinical Trials Explore Clinical Trials Conduct of Clinical Trials & Postmarketing Commitments Clinical Trials Data & Information Sharing Products Innovators at AbbVie Our Science Stories Responsibility Explore Responsibility Patient Health & Well-Being Explore Patient Health & Well-Being Research for Better Outcomes Ethics, Safety and Quality Patient, Family and Caregiver Well-Being Making Medicines Accessible Supporting our Workforce Explore Supporting our Workforce Diversity & Development Human Rights and Workplace Safety Employee Well-Being Communities & Environment Explore Communities & Environment Health for the Underserved Long-Term Community Strength Environmental Sustainability Going Beyond: Meaningful Impact AbbVie Foundation Explore AbbVie Foundation Ways We Help Focus Foundation Partners AbbVie Grants Explore AbbVie Grants How to Apply Request Types Requestor Training Guides Grants and Contributions Disclosures Responsibility Stories Careers Explore Careers Search All Jobs Benefits Equality, Diversity & Inclusion Explore Equality, Diversity & Inclusion Employee Resource Groups Roles Explore Roles Corporate Research & Development Operations Commercial Business Technology Solutions U.S. Student Opportunities U.S. Professional Programs AbbVie Around the World Our People Stories Partnerships Explore Partnerships Our Approach Areas of Interest AbbVie Ventures Explore AbbVie Ventures Team Portfolio Additional Collaboration Opportunities Explore Additional Collaboration Opportunities Open Innovation Program Investigator-Initiated Studies (IIS) Contract Manufacturing Investors News Center Patients Toggle Ancillary Navigation Close Search 24C1F2D2-A1A6-4D15-982D-20E53E43CC8B Type in your search... Toggle Ancillary Navigation AbbVie's COVID-19 update Learn about our charitable giving and all we’re doing to respond to the coronavirus crisis. See how Feature AbbVie donates $35 million for COVID-19 relief efforts Patients For patients who have lost insurance coverage related to COVID-19, we are here to help. Feature AbbVie and Allergan Our approach to innovation builds on strong science combined with the drive to find solutions where the need is the greatest Our science Pipeline Advancing medicines with strong clinical performance in areas of great need Focus areas Driving innovation across oncology, immunology, neuroscience and more Careers Work with us to turn world-class research into life-changing results Passionate about our work, responsible in our actions—we go beyond medicine to improve health care and our communities Responsibility 40,000 employee volunteer service hours during 2019 Week of Possibilities 574 grants across 35 disease areas provided by AbbVie 22% reduction in global water intake, 2013-2015, normalized to sales and excluding non-contact cooling water By putting patients first, we explore new medical innovations and ways to enhance access Patients If we bring a new medicine to market, it can help patients worldwide, as opposed to the 20 or so patients we might see in clinic in one day. That's what drives me. It's the greater impact we can have by working here at AbbVie. Kyle Holen, M.D., Head, Development Design Center AbbVie combines advanced science, expertise and passion to solve the world’s most serious health issues and have a remarkable impact on people’s lives Our company 2019 Dow Jones Sustainability World Index AbbVie was named to the DJSI World Index for the seventh year in a row for our responsible economic, environmental and social performance 2018 Civic 50 For the fifth year in a row, AbbVie was recognized as one of America’s most community-minded companies and honored for our commitment to improve quality of life in communities where we live and work DiversityInc Top 50 Companies for Diversity 2018 AbbVie has been recognized as one of the 50 most diverse companies for the sixth year straight. This list includes companies excelling in areas of recruitment, talent development, leadership, commitment and supplier diversity Stories Suppliers Contact Medical Information Site Map Privacy Policy Terms of Use Copyright © 2020 AbbVie Inc. North Chicago, Illinois, U.S.A. Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company. This site uses cookies to personalize content, save your preferences and track the site’s performance. Learn more, including how to disable certain cookies on our Privacy Page . Click OK to continue. OK × You are about to leave the AbbVie website The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site? Yes I agree No I disagree × You are about to leave for a 3rd party website The link below will take you out of the AbbVie family of websites. Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie. The Internet site that you have requested may not be optimized to your screen size. Do you wish to leave this site? Yes Accept Default Reject Description Learn More Disclaimer Notice - Important Recommended Offer for Allergan plc (“Allergan”) by AbbVie Inc. (“AbbVie”) (the “Acquisition”) by means of a scheme of arrangement under Irish law (the “Scheme”). You are attempting to enter the section of this website that is designated for the publication of documents and information in connection with the offer by AbbVie for Allergan announced on June 25, 2019 (the “Offer”). ACCESS TO THIS SECTION OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION), BEFORE YOU MAY OBTAIN AC...